Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Indian Health Authorities: 700 Died in Flu Outbreak

By Drug Discovery Trends Editor | February 20, 2015

Health authorities were working to ensure remote hospitals in northern and western India had adequate medical supplies for a flu outbreak that has claimed more than 700 lives in 10 weeks.

More than 11,000 cases have been reported since mid-December with most of the cases being reported from Rajasthan, Gujarat, Maharashtra, Telangana and Madhya Pradesh states.

Federal health minister J.P. Nadda asked people to remain alert and not panic as the numbers climbed. At a meeting Thursday, top health officials were told to ensure that medicines were freely available and 24-hour helplines were set up.

The ministry was closely monitoring the situation but there was no shortage of drugs to treat patients, its statement said. The preparedness of government-run hospitals and health clinics in the worst affected states was being watched and the availability of drugs monitored.

Health authorities have also launched a campaign over television and radio to tell people about precautions they should take to avoid the flu.

Although it was being referred to as swine flu, doctors say it is a variant of the H1N1 pandemic influenza.

In the northern state of Uttar Pradesh, where six deaths were reported over the past two weeks, Chief Minister Akhilesh Yadav said patients would get free treatment in state-run hospital.

Doctors said casualties were high because patients delay going to hospitals and have urged people to get tested as soon as they feel symptoms.

The Delhi government capped the cost of tests by private labs at 4,500 rupees ($72) to stop exorbitant fees.

Health ministry officials say they expect the cases to decline as the weather warms.

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Bayer’s Lynkuet approved by FDA for menopausal hot flashes
How stereo-correct data can de-risk AI-driven drug discovery
eConsent as the digital foundation for modern clinical trials 
Female Patient Being Reassured By Doctor In Hospital Room
Q&A: Thermo Fisher’s Luke Wilson on hitting 100% dose delivery with patient-centric supply
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE